Immatics director granted 48,000 stock options

Q: What insider transaction did Immatics (IMTX) report in this Form 4?

The Form 4 reports that director Carter Paul Rutherford received a grant of stock options. These options cover 48,000 Ordinary Shares of Immatics N.V. as a compensation-related award, not an open-market trade.

Q: How many Immatics (IMTX) shares are covered by the new stock options?

The granted stock options cover 48,000 Ordinary Shares of Immatics N.V. This means the director can buy up to 48,000 shares at the fixed exercise price if the options vest and are exercised.

Q: What is the exercise price of the new Immatics (IMTX) stock options?

The stock options have an exercise price of $9.09 per share. This is the price at which the director can purchase Immatics Ordinary Shares once the options are vested and exercised.

Q: When do the Immatics (IMTX) options granted to Carter Paul Rutherford vest?

According to the footnote, the options vest 100% on the first anniversary of the grant date, June 16, 2026. No portion vests before that date based on the disclosed terms.

Q: When do the newly granted Immatics (IMTX) stock options expire?

The stock options expire on June 15, 2036. After this expiration date, any unexercised options will lapse and can no longer be used to purchase Immatics Ordinary Shares.

Q: Did the Immatics (IMTX) director buy or sell shares in the market?

No, this Form 4 shows a grant of stock options, not an open-market share purchase or sale. It is a compensation-related award giving the right to buy shares in the future.

Immatics N.V. director Carter Paul Rutherford received a grant of stock options covering 48,000 Ordinary Shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Immatics N.V. director Carter Paul Rutherford received a grant of stock options covering 48,000 Ordinary Shares. The options have an exercise price of $9.09 per share and expire on June 15, 2036. According to the footnote, the options vest 100% on the first anniversary of the grant date, June 16, 2026. This is a compensation-related award, not an open-market share purchase or sale.

Insider Trade Summary

Grant/Award: 48,000 shares

Grant/Award 1 txn

Insider Carter Paul Rutherford

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	48,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 48,000 contracts (Direct)

Footnotes (1)

F1. These Options vest 100% on the first anniversary of the grant date, June 16, 2026.

Key Figures

Option grant size: 48,000 options Exercise price: $9.09 per share Underlying shares: 48,000 Ordinary Shares +2 more

5 metrics

Option grant size 48,000 options Stock Option (Right to Buy) granted to director

Exercise price $9.09 per share Conversion or exercise price for granted options

Underlying shares 48,000 Ordinary Shares Shares subject to the stock options

Vesting date June 16, 2026 Options vest 100% on first anniversary of grant

Expiration date June 15, 2036 Expiration of granted stock options

Key Terms

Stock Option (Right to Buy), Ordinary Shares, exercise price, vest 100%, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"conversion_or_exercise_price of $9.0900 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest 100% financial

"These Options vest 100% on the first anniversary of the grant date"

expiration date financial

"expiration_date: 2036-06-15T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Immatics (IMTX) report in this Form 4?

The Form 4 reports that director Carter Paul Rutherford received a grant of stock options. These options cover 48,000 Ordinary Shares of Immatics N.V. as a compensation-related award, not an open-market trade.

How many Immatics (IMTX) shares are covered by the new stock options?

The granted stock options cover 48,000 Ordinary Shares of Immatics N.V. This means the director can buy up to 48,000 shares at the fixed exercise price if the options vest and are exercised.

What is the exercise price of the new Immatics (IMTX) stock options?

The stock options have an exercise price of $9.09 per share. This is the price at which the director can purchase Immatics Ordinary Shares once the options are vested and exercised.

When do the Immatics (IMTX) options granted to Carter Paul Rutherford vest?

According to the footnote, the options vest 100% on the first anniversary of the grant date, June 16, 2026. No portion vests before that date based on the disclosed terms.

When do the newly granted Immatics (IMTX) stock options expire?

The stock options expire on June 15, 2036. After this expiration date, any unexercised options will lapse and can no longer be used to purchase Immatics Ordinary Shares.

Did the Immatics (IMTX) director buy or sell shares in the market?

No, this Form 4 shows a grant of stock options, not an open-market share purchase or sale. It is a compensation-related award giving the right to buy shares in the future.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/18/2026 - 04:44 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carter Paul Rutherford

(Last)

(First)

(Middle)

PAUL-EHRLICH-STR. 15

(Street)

GERMANY

72076

(City)

(State)

(Zip)

JORDAN

(Country)

2. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$9.09	06/16/2026		A		48,000		⁽¹⁾	06/15/2036	Ordinary Shares	48,000	$0	48,000	D

Explanation of Responses:

1. These Options vest 100% on the first anniversary of the grant date, June 16, 2026.

	/s/ Edward Sturchio, attorney-in-fact for Paul Rutherford Carter	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR